CMS Reversal on Avastin
Powerful news: the CMS reversal on Avastin® reimbursement is immediate and retroactive.
Thanks to your efforts, and those of your colleagues, patients and members of Congress, the Centers for Medicare & Medicaid Services (CMS) rescinded its decision to change the reimbursement amount for Avastin® (Bevacizumab). You can continue to prescribe the medication you prefer — without sacrificing the financial health of your practice. The United States Senate Special Committee on Aging praised the decision.
CMS announced that the reversal is effective immediately, and will be retroactive to October 1, 2009. This is a huge victory for practitioners like you who want to be able to choose the treatment they deem appropriate for their patients, without paying a financial penalty. Because we know that you care about quality and cost, Wedgewood Pharmacy provides high-quality, single-use Bevacizumab syringes at prices that are affordable for you and your patients.